aabb-logo-sm

Standards for Cellular Therapy Services

Standards for Cellular Therapy Services, 11th Edition Print

Outlines requirements for the donor eligibility and collection, processing, storage, and administration of any type of cellular therapy product.

Current edition: 11th edition
Effective date: July 1, 2023
Revision cycle: 24 months (July of odd numbered years)


Purchase Standards

Acquiring Standards

The print and Portal versions of the 11th edition of Standards for Cellular Therapy Services, are available for purchase.


Related Information

  • Response to Comments and Significant Changes to the 11th edition of CT Standards
  • Response to Comments and Significant Changes to the 10th edition of CT Standards.
  • Responses to Public Comments to the 9th edition of CT Standards.
    For a complete look at the significant changes that have been made to the 10th edition, please refer to the Guidance within the Standards Portal or by purchasing the printed bundle of Standards and Guidance.

Accreditation Activities

AABB sets standards for and accredits facilities that procure, process, store and/or distribute cellular therapy products. The Standards for Cellular Therapy Services outlines the standards used as a basis for accreditation in cellular therapies activities, including:

Cord Blood (CB) Services

These facilities are responsible for procuring, processing and storing umbilical cord blood stem cells that can be used for transplantation.

Hematopoietic Progenitor Cell (HPC) Services

These facilities are responsible for procuring, processing and storing hematopoietic progenitor cells that can be used for transplantation.

Somatic Cell Services

These facilities perform one or more of the manufacturing steps for somatic cell products, including procurement, processing, storing and/or distributing.

Cellular Therapy Clinical Services

These facilities are responsible for the administration of the product and all related patient care activities.